Sepsis Diagnostics Market Projected to Grow at a Steady Pace During 2022-2027

Stratview Research has published a new report titled “Sepsis Diagnostics Market” which is segmented by Technology Type (Microbiology, Molecular Diagnostic, Immunoassay, and Biomarkers), by Testing Type (Blood Culture Media and Instruments), by Testing Mode Type (Automated and Semi-Automated), by Testing Site Type (Laboratory-Based and Patient Bed Side (POC)), by Sepsis Type (Pathogen, Bacterial, and Fungal), by Testing Facility Type (Hospitals & Clinics, Pathology Laboratories, and Others), and by Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The UK, Russia, and Rest of Europe], Asia-Pacific [China, Japan, India, and Rest of Asia-Pacific], and Rest of the World [Brazil, Saudi Arabia, and Others]).

As per the study, the market is likely to grow at a promising CAGR of 9.0% during the forecast period.

Read more: https://www.stratviewresearch.com/412/sepsis-diagnosis-market.html

Major factors such as the growing number of infectious diseases, the rising number of sepsis incidences, and technological advancements in the field of sepsis diagnostics are expected to drive the growth of the market during the forecast period.

Report Highlights
This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides a thorough analysis of the market segments which include products, applications, and competitor analysis.

The market is bifurcated into various segments. Below given is the segment-wise analysis -
By Technology Type
The sepsis diagnostics market is segmented as microbiology, molecular diagnostic, immunoassay, and biomarkers. Microbiology is expected to remain the largest technology type segment of the market during the forecast period owing to the low cost of microbiology techniques and accurate detection of microorganisms for sepsis diagnosis.
The molecular segment is expected to be the fastest-growing segment during the forecast period due to high accuracy and less turnaround time.

By Testing Type
The market is segmented as blood culture media and instruments. Blood culture media is expected to remain the dominant as well as the faster-growing testing type in the market during the forecast period, due to increasing demand for blood culture media by hospitals and pathology labs. In addition, the convenience and cost-effectiveness of blood culture media are further expected to fuel the growth of the market in the coming years.

By Sepsis Type
The market is segmented as pathogen, bacterial, and fungal. Bacterial sepsis is expected to hold the largest share of the market during the forecast period, due to the rise in bacterial sepsis cases, the increasing frequency of hospital-transmitted infections, and the increasing number of surgical procedures performed.

By Testing Site Type
The market is segmented as laboratory-based and patient bedside (POC). Laboratory testing is expected to remain the larger segment of the market during the forecast period. Major factors such as higher accuracy in comparison to POC testing, in-depth analysis, and an increasing number of diagnostic laboratories are driving the growth of the segment.

Which Region is expected to remain the largest market?
North America is expected to be the largest market for sepsis diagnostics during the forecast period. The region has a large healthcare infrastructure, and factors such as the adoption of advanced diagnostic solutions, the rising number of infectious diseases, and the presence of key players in the region all contribute to the region's market growth.
Asia-Pacific and Europe are also likely to create sizeable growth opportunities in the coming five years.

Who are the Key Players in the Market?
This report provides market intelligence most comprehensively. It also provides critical insights into the key players active in the market, which will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players active in the Sepsis Diagnostics Market:
• Abbott Laboratories
• Becton, Dickinson, and Company
• bioMérieux SA
• Bruker Corporation
• Cerner Corporation
• Danaher Corporation
• F. Hoffmann-La Roche
• GE Healthcare
• Luminex Corporation
• Thermo Fisher Scientific, Inc.

Key questions answered by the report.
• What is the projected CAGR for revenue from the Sepsis Diagnostics Market during the forecast period?
• What would the market be valued at by 2027?
• What is a major driving factor for the growth of the market?
• Which region accounted for the largest revenue share in the Sepsis Diagnostics Market?
• Which are the major market players?

Custom Research:
Stratview Research delivers custom research services across sectors. In case of any custom research requirements, please send your inquiry to [email protected]. Or connect with our experts at +1-313-307-4176.

About Us
Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision-making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.